What 5 Analyst Ratings Have To Say About Acelyrin
Portfolio Pulse from Benzinga Insights
Acelyrin (NASDAQ:SLRN) has received 5 analyst ratings in the last quarter, with 3 being bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for Acelyrin is $32.4, with a high of $44.00 and a low of $19.00, representing a 4.71% decrease from the previous target of $34.00. Analysts rate stocks based on research and provide guidance to investors, though their opinions are not infallible.
November 28, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acelyrin has received mostly positive analyst ratings with an average 12-month price target of $32.4, indicating a slight decrease from the previous target.
The majority of analyst ratings are bullish or somewhat bullish, which could lead to increased investor confidence and a potential short-term increase in stock price. However, the decrease in the average price target may temper expectations slightly.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100